Literature DB >> 20624248

Characterization of 33 488 children and adolescents with type 1 diabetes based on the gender-specific increase of cardiovascular risk factors.

K Otfried Schwab1, Juergen Doerfer, Wolfgang Marg, Edith Schober, Reinhard W Holl.   

Abstract

OBJECTIVES: Characterization of children with type 1 diabetes (T1DM) regarding number and gender distribution of cardiovascular risk factors (cvRF) and of total cholesterol/high-density lipoprotein cholesterol ratio (TC/HDL-C ratio) for risk assessment.
METHODS: 33488 patients <or=18 years were included in this cross-sectional analysis and placed into 5 categories by their number of cvRF. Dyslipidemia (TC >200 mg/dL, >5.17 mmol/L; and/or HDL-C <35 mg/dL, <0.91 mmol/L; and/or LDL-C >130 mg/dL, >3.36 mmol/L), elevated systolic and/or diastolic blood pressure (BP) >or=90th percentile, obesity >97th percentile, active smoking, and HbA1c >or=7.5% were considered as cvRF.
RESULTS: 65% had no or 1 cvRF. HbA1c >/=7.5% was the most frequently occurring cvRF followed by BP >or=90th percentile, dyslipidemia, smoking, and BMI >97th percentile. Age at diabetic onset ranged from 7.7 to 9.2 years and diabetes duration from 4.1 to 6.6 years. CvRF showed differences in disfavour of females except smoking and HDL-C <35 mg/dL (0.91 mmol/L). Rate of females was 45% with 0 cvRF and 60% with 4 to 5 cvRF. TC/HDL-C ratio showed no clear association to the number of cvRF.
CONCLUSIONS: 35% of a pediatric T1DM population develops 2 or more cvRF thus increasing their cv risk in adulthood. With increasing numbers of cvRF, the percentage of girls is rising from 45% to 60% which might contribute to an assimilation of survival rates in female and male adults. TC/HDL ratio does not predict the extent of cardiovascular risk in pediatric T1DM.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20624248     DOI: 10.1111/j.1399-5448.2010.00665.x

Source DB:  PubMed          Journal:  Pediatr Diabetes        ISSN: 1399-543X            Impact factor:   4.866


  20 in total

Review 1.  Cardiovascular disease risk in young people with type 1 diabetes.

Authors:  Janet K Snell-Bergeon; Kristen Nadeau
Journal:  J Cardiovasc Transl Res       Date:  2012-04-12       Impact factor: 4.132

Review 2.  Macrovascular disease and risk factors in youth with type 1 diabetes: time to be more attentive to treatment?

Authors:  Petter Bjornstad; Kim C Donaghue; David M Maahs
Journal:  Lancet Diabetes Endocrinol       Date:  2018-02-20       Impact factor: 32.069

Review 3.  Risks and benefits of statin use in young people with type 1 diabetes.

Authors:  Petter Bjornstad; R Paul Wadwa
Journal:  Curr Diab Rep       Date:  2014-07       Impact factor: 4.810

4.  Clinical, Psychosocial, and Demographic Factors Are Associated With Overweight and Obesity in Early Adolescent Girls With Type 1 Diabetes.

Authors:  Karl E Minges; Robin Whittemore; Ariana M Chao; Vanessa Jefferson; Kathryn M Murphy; Margaret Grey
Journal:  Diabetes Educ       Date:  2016-06-13       Impact factor: 2.140

Review 5.  Pathogenesis of Lipid Disorders in Insulin Resistance: a Brief Review.

Authors:  Petter Bjornstad; Robert H Eckel
Journal:  Curr Diab Rep       Date:  2018-10-17       Impact factor: 4.810

Review 6.  Cardiovascular function/dysfunction in adolescents with type 1 diabetes.

Authors:  Kristen J Nadeau; Jane E B Reusch
Journal:  Curr Diab Rep       Date:  2011-06       Impact factor: 4.810

7.  Drug therapy of hypercholesterolaemia in children and adolescents.

Authors:  Marjet J A M Braamskamp; Frits A Wijburg; Albert Wiegman
Journal:  Drugs       Date:  2012-04-16       Impact factor: 9.546

8.  Comparison of cystic fibrosis-related diabetes with type 1 diabetes based on a German/Austrian Pediatric Diabetes Registry.

Authors:  Katja Konrad; Angelika Thon; Maria Fritsch; Elke Fröhlich-Reiterer; Eggert Lilienthal; Stefan A Wudy; Reinhard W Holl
Journal:  Diabetes Care       Date:  2012-12-13       Impact factor: 19.112

9.  Approach to lipid screening as a risk marker for cardiovascular disease in pediatric patients with diabetes.

Authors:  Jennifer Rachel Law; Shipra Patel; Anna Spagnoli
Journal:  Front Endocrinol (Lausanne)       Date:  2011-10-11       Impact factor: 5.555

10.  Prevalence, awareness, and treatment of hypertension in patients with type 1 diabetes: a nationwide multicenter study in Brazil.

Authors:  Marilia B Gomes; Lucianne Righeti Monteiro Tannus; Alessandra Saldanha de Mattos Matheus; Roberta Arnoldi Cobas; Catia C Sousa Palma; Aline Tiemi Kano Silva; Carlos Antonio Negrato; Sergio Atala Dib; Melanie Rodacki; João Soares Felício; Luis Henrique Canani
Journal:  Int J Hypertens       Date:  2013-03-04       Impact factor: 2.420

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.